Selective Serotonin Reuptake Inhibitors in pediatric psychopharmacology: A review of the evidence
Authors:
- Fé M. VivasFVFé M. Vivas
- Daniel A. GellerDGDaniel A. Geller
- 1 February 2006
- journal article
- review article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 148 (2) , 158-165
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Cerebrovascular Effects of Selective Serotonin Reuptake InhibitorsThe Journal of Clinical Psychiatry, 2004
- Treatment emergent affective switch: a controlled studyBipolar Disorders, 2004
- Impact of Comorbidity on Treatment Response to Paroxetine in Pediatric Obsessive-Compulsive Disorder: Is the Use of Exclusion Criteria Empirically Supported in Randomized Clinical Trials?Journal of Child and Adolescent Psychopharmacology, 2003
- Switching, Cycling, and Antidepressant-Induced Effects on Cycle Frequency and Course of Illness in Adult Bipolar Disorder: A Brief Review and CommentaryJournal of Child and Adolescent Psychopharmacology, 2003
- Myoclonus During Prolonged Treatment with Sertraline in an Adolescent PatientJournal of Child and Adolescent Psychopharmacology, 2001
- Withdrawal Symptoms Associated With Paroxetine Discontinuation in a Nine-Year-Old BoyJournal of Clinical Psychopharmacology, 2000
- Depression in anxious children: Possible factors in comorbidityDepression and Anxiety, 1999
- Sertraline Treatment of 5 Children Diagnosed with Selective Mutism: A Single-Case Research TrialJournal of Child and Adolescent Psychopharmacology, 1999
- The Effect of Fluoxetine on Sleep EEG in Childhood Depression: A Preliminary ReportNeuropsychopharmacology, 1997
- An Open Study of the Effects of Sertraline on Adolescent Major DepressionJournal of Child and Adolescent Psychopharmacology, 1996